Friday, May 24, 2024
HomeHealth & FitnessDrugsRecent Increase Seen in Pediatric Benzonatate Exposure

Recent Increase Seen in Pediatric Benzonatate Exposure

Date:

Related stories

Sports I’ve Considered

Our summer style icon is Tashi Duncan. By...

5 Ways Senior Women Can Be a Blessing to Others

Being a conduit of God’s love to others...

Animal Well And More Made May The Month Of Puzzle Games

At the beginning of this year, I could...

Wait, Since When Does Cher Have a Nose Ring? See Photos

I didn't start getting tattoos until 10 years...

Compass CEO Robert Reffkin Says The Luxury Market Is Back

The luxury market is back. That was Compass...
spot_imgspot_img


TUESDAY, Nov. 15, 2022 — Pediatric benzonatate prescription utilization has increased recently, as have cases involving intentional benzonatate exposure, according to a study published online Nov. 15 in Pediatrics.

Ivone Kim, M.D., from the U.S. Food and Drug Administration in Silver Spring, Maryland, and colleagues conducted a retrospective analysis of data to examine recent trends in benzonatate exposure (2012 to 2019) and the clinical consequences for pediatric patients.

The researchers observed an increase in pediatric benzonatate prescription utilization during the study period, but it remained low compared with pediatric utilization of dextromethorphan-containing prescription antitussive medications. Eighty percent of the 4,689 pediatric benzonatate exposure cases reported to U.S. poison control centers in 2010 to 2018 were for single-substance exposures; 77 percent were unintentional exposures. Most of these cases (2,718 cases; 83 percent) involved children aged 0 to 5 years. There was an increase seen in cases involving intentional benzonatate exposure among children aged 10 to 16 years, with a more pronounced increase for multiple-substance exposures. Children aged 10 to 16 years accounted for 61 percent of benzonatate cases involving misuse or abuse. A low proportion of cases had serious adverse effects; among children, few cases of serious adverse events with benzonatate were seen annually.

“Anticipatory guidance at the time of benzonatate prescribing should include discussions with patients and caregivers about keeping benzonatate out of reach of children to avoid unintentional ingestions in younger children and potential misuse and use for suicide attempts by older children,” the authors write.

Abstract/Full Text (subscription or payment may be required)

© 2022 HealthDay. All rights reserved.

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.



Source link

Latest stories

spot_img